SeaSpine to see 2017 revenue of $34M+ — 7 observations

Megan Wood -   Print  |

SeaSpine released its preliminary financial results for the fourth quarter and full year of 2017.

Here are seven observations:


1. For the fourth quarter of 2017, SeaSpine will likely see revenue between $34.2 million and $34.4 million, a 6 percent increase from the fourth quarter of 2016.


2. U.S. fourth quarter revenue will likely be $31.5 million, reflecting a 6 percent boost from the same period the year prior.


3. The U.S. orthobiologics segment will see revenues of $16.9 million, a 12 percent jump from the fourth quarter of 2016.


4. SeaSpine reports its U.S. spinal implants revenue will likely stay at $14.6 million.


5. The company's FY 2017 revenue will fall between $132 million and $132.2 million, a 2.5 percent increase from FY 2016.


6. As of Dec. 31, 2017, SeaSpine had cash and cash equivalents of $10.8 million.


7. For 2018, SeaSpine anticipates revenue between $135 million and $139 million.


More articles on devices:
Medtronic, DePuy Synthes & more: 8 device company mergers, acquisitions & agreements
DJO Global reports patient information breach at Las Vegas hospital: 5 things to know
NuVasive's US procedure volumes stay slow in 2017, international revenue up: 5 things to know



© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers